“MOLECULAR DOCKING VIRTUAL SCREENING, DRUG-LIKENESS AND PHARMACOKINETICS (ADMET) PROPERTIES PREDICTION OF SOME ENDOMETRIAL CANCER AGENTS”, FJS, vol. 5, no. 4, pp. 361–367, Feb. 2022, doi: 10.33003/fjs-2021-0504-833.